Oxytocin injection may reduce retained placenta risk after termination
NCT ID NCT02969447
First seen May 15, 2026 · Last updated Jun 18, 2026 · Updated 6 times
Summary
This study tested whether giving oxytocin (a drug that helps the uterus contract) after a second-trimester medical pregnancy termination reduces the chance of retained placenta. 27 women participated. The goal was to see if this simple step could lower the need for additional procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PLACENTA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Bordeaux
Bordeaux, 33076, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.